The partnership between Japan and the Democratic Republic of the Congo to provide monkeypox (MPOX) vaccines is a major step forward in the fight against infectious diseases in the DRC. The signing of this agreement demonstrates the commitment of both countries to strengthen their cooperation in the field of public health.
The announcement of the provision of monkeypox vaccines by Japan comes at a time when the DRC is facing major health challenges. Monkeypox, an emerging viral disease transmitted by primates, poses a serious threat to the Congolese population. The provision of effective vaccines against this disease is therefore crucial to prevent its spread and protect the health of citizens.
Vice Minister of Foreign Affairs Gracia Yamba Kazadi stressed the importance of this agreement for the development of the country and the well-being of its people. She welcomed Japan’s contribution and underlined the shared commitment to combating health crises.
Japanese diplomat Ogawa Hidetoshi also expressed his willingness to support the DRC in this fight against monkeypox. He called for effective coordination between the Congolese authorities, international organizations and Japan to ensure the success of the vaccination campaign.
In addition to the supply of vaccines, another agreement was signed to relaunch the project to build a Judo Training Center for the Congolese National Police. This initiative will help build the capacity of Congolese law enforcement and promote sport within the community.
In conclusion, the signing of these agreements marks an important step in the cooperation between the DRC and Japan. It demonstrates the willingness of both countries to work together to address common challenges and improve the health and well-being of populations. This exemplary collaboration paves the way for new ambitious projects and strengthens ties between the two nations.